MannKind

+$0.16 (+4.26%) Today

-$0.02 (-0.51%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

CEO

Michael E. Castagna

Employees

241

Headquarters

Danbury, Connecticut

Founded

1991

MNKD Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

2.43M

High today

$3.95

Low today

$3.68

Open price

$3.72

Volume

2.91M

52 Week high

$6.25

52 Week low

$3.12

MNKD News

ReutersJan 14

MNKD.OQ - MannKind Corporation Profile

About MannKind Corporation MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled ther

Simply Wall StJan 11

How Much Of MannKind Corporation Do Institutions Own?

The big shareholder groups in MannKind Corporation (NASDAQ:MNKD) have power over the company. Insiders often own a large chunk of younger, smaller, companies wh

Analyst ratings

Buy

83.3%

Hold

16.7%

Sell

MNKD Earnings

-$0.07

-$0.05

-$0.02

$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Feb 23, After Hours

Why Robinhood?

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. View more

MNKD.OQ - MannKind Corporation Profile

How Much Of MannKind Corporation Do Institutions Own?

83%

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.